Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
J Clin Invest. 2011 Oct;121(10):3834-45. doi: 10.1172/JCI37210. Epub 2011 Sep 19.
A fundamental goal in cancer research is the identification of the cell types and signaling pathways capable of initiating and sustaining tumor growth, as this has the potential to reveal therapeutic targets. Stem and progenitor cells have been implicated in the genesis of select lymphoid malignancies. However, the identity of the cells in which mature lymphoid neoplasms are initiated remains unclear. Here, we investigate the origin of peripheral T cell lymphomas using mice in which Snf5, a chromatin remodelling-complex subunit with tumor suppressor activity, could be conditionally inactivated in developing T cells. In this model of mature peripheral T cell lymphomas, the cell of origin was a mature CD44hiCD122loCD8⁺ T cell that resembled a subset of memory cells that has capacity for self-renewal and robust expansion, features shared with stem cells. Further analysis showed that Snf5 loss led to activation of a Myc-driven signaling network and stem cell transcriptional program. Finally, lymphomagenesis and lymphoma proliferation depended upon TCR signaling, establishing what we believe to be a new paradigm for lymphoid malignancy growth. These findings suggest that the self-renewal and robust proliferative capacities of memory T cells are associated with vulnerability to oncogenic transformation. Our findings further suggest that agents that impinge upon TCR signaling may represent an effective therapeutic modality for this class of lethal human cancers.
癌症研究的一个基本目标是确定能够启动和维持肿瘤生长的细胞类型和信号通路,因为这有可能揭示治疗靶点。干细胞和祖细胞已被牵涉到某些淋巴恶性肿瘤的发生。然而,成熟淋巴细胞肿瘤起源的细胞身份仍不清楚。在这里,我们使用 Snf5 条件性失活的发育中的 T 细胞的小鼠来研究外周 T 细胞淋巴瘤的起源,Snf5 是一种具有肿瘤抑制活性的染色质重塑复合物亚基。在这种成熟外周 T 细胞淋巴瘤模型中,起源细胞是一种成熟的 CD44hiCD122loCD8+T 细胞,类似于具有自我更新和强大扩增能力的记忆细胞亚群,这些特征与干细胞共享。进一步的分析表明,Snf5 的缺失导致了 Myc 驱动的信号网络和干细胞转录程序的激活。最后,淋巴瘤的发生和淋巴瘤的增殖依赖于 TCR 信号,这建立了我们认为是淋巴恶性肿瘤生长的新范例。这些发现表明,记忆 T 细胞的自我更新和强大增殖能力与致癌转化的易感性有关。我们的发现进一步表明,抑制 TCR 信号的药物可能代表治疗这类致命人类癌症的有效治疗方式。